Treatments for diabetes – the latest advances including Glifozins, Incretins, DPP-4 inhibitors & mor
Saturday, November 23, 2013
"The alarming pace at which diabetes is flourishing worldwide poses the greatest challenge to the healthcare industry. Although the pharmaceutical market is flooded with a wide array of drugs for the treatment and management of type 1 and type 2 diabetes, a few limitations have led to the development of new and improved drugs. The currently used medications are intended to boost insulin production, lower insulin resistance, reduce the production of glucose by the liver or slow down the absorption of carbohydrates by the intestine. These drugs may effectively restore normal blood glucose levels, but, they do not have any effect on the progression of the disease, and reduce in efficacy over time. Moreover, some drugs do have certain severe side effects that further worsen co-morbid conditions."
Prevention is the key.